Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other 2Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Obesity 28Neoplasms 10Overweight 8Breast Neoplasms 7Dyspnea 6Sexual Dysfunction, Physiological 5Mucositis 5Endometrial Neoplasms 5Pediatric Obesity 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 3Motor Activity 3Diabetes Mellitus, Type 2 3Weight Loss 2Uterine Cervical Neoplasms 2Syndrome 2Stomatitis 2Pulmonary Disease, Chronic Obstructive 2Pain 2Obesity-Related Malignant Neoplasm 2Leukemia 2Insulin Resistance 2Infertility 2Fatigue 2Endometrial Hyperplasia 2Cough 2Constipation 2Colorectal Neoplasms 2Vomiting 1Ulcer 1

Interventions

Tirzepatide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Insulin Resistance × Other × 90 days × Clear all
NCT05950282 2026-05-01

DAISY

Lilli Health

Recruiting
150 enrolled
Other

Diabetes Mellitus, Type 2, Hyperinsulinism, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Metabolic Syndrome

NCT07065552 2026-04-28

Tirzepatide in Obesity-Driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Recruiting
20 enrolled
GynecologicOther

Insulin Resistance, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡